JP2005533800A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533800A5
JP2005533800A5 JP2004514806A JP2004514806A JP2005533800A5 JP 2005533800 A5 JP2005533800 A5 JP 2005533800A5 JP 2004514806 A JP2004514806 A JP 2004514806A JP 2004514806 A JP2004514806 A JP 2004514806A JP 2005533800 A5 JP2005533800 A5 JP 2005533800A5
Authority
JP
Japan
Prior art keywords
liver
composition
use according
composition according
regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004514806A
Other languages
English (en)
Japanese (ja)
Other versions
JP5144876B2 (ja
JP2005533800A (ja
Filing date
Publication date
Priority claimed from DE2002127611 external-priority patent/DE10227611A1/de
Application filed filed Critical
Priority claimed from PCT/EP2003/006509 external-priority patent/WO2004001023A2/de
Publication of JP2005533800A publication Critical patent/JP2005533800A/ja
Publication of JP2005533800A5 publication Critical patent/JP2005533800A5/ja
Application granted granted Critical
Publication of JP5144876B2 publication Critical patent/JP5144876B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004514806A 2002-06-20 2003-06-20 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス Expired - Lifetime JP5144876B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE2002127611 DE10227611A1 (de) 2002-06-20 2002-06-20 Verfahren und Vorrichtung zur Vermehrung und Differenzierung von Zellen in Anwesenheit von Wachstumsfaktoren und einer biologischen Matrix oder Trägerstruktur
DE10227611.0 2002-06-20
DE10234204 2002-07-26
DE10234204.0 2002-07-26
PCT/EP2003/006509 WO2004001023A2 (de) 2002-06-20 2003-06-20 Verfahren und vorrichtung zur vermehrung und differenzierung von zellen in anwesenheit von wachstumsfaktoren und einer biologischen matrix oder trägerstruktur

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010118753A Division JP2010209110A (ja) 2002-06-20 2010-05-24 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス

Publications (3)

Publication Number Publication Date
JP2005533800A JP2005533800A (ja) 2005-11-10
JP2005533800A5 true JP2005533800A5 (https=) 2010-01-28
JP5144876B2 JP5144876B2 (ja) 2013-02-13

Family

ID=30001461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004514806A Expired - Lifetime JP5144876B2 (ja) 2002-06-20 2003-06-20 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス
JP2010118753A Pending JP2010209110A (ja) 2002-06-20 2010-05-24 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010118753A Pending JP2010209110A (ja) 2002-06-20 2010-05-24 増殖因子を用いて、および生物学的マトリクスあるいは支持構造を用いて細胞を増殖および分化する方法およびデバイス

Country Status (9)

Country Link
US (2) US20060035374A1 (https=)
EP (1) EP1517988B1 (https=)
JP (2) JP5144876B2 (https=)
CN (2) CN101766809A (https=)
AU (1) AU2003253015A1 (https=)
CA (1) CA2495395C (https=)
DK (1) DK1517988T3 (https=)
ES (1) ES2422881T3 (https=)
WO (1) WO2004001023A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026480A1 (de) * 2000-05-29 2001-12-13 Augustinus Bader Verfahren zur Herstellung eines empfängerspezifischen Gewebe-Transplantats oder -Implantats
KR20050071498A (ko) * 2002-09-18 2005-07-07 상트르 오스피딸리에 드 루니버시떼 드 몬트리알 성장 호르몬 방출 호르몬 유사체
EP1550715A1 (de) * 2003-12-30 2005-07-06 Bionethos Holding Gmbh Verfahren zur Regenation von Gewebe
ATE469654T1 (de) * 2003-12-30 2010-06-15 Augustinus Bader Verwendung des erythropoietins zur regeneration von lebergewebe
FR2870739B1 (fr) * 2004-05-26 2008-05-16 Oreal Utilisation du lif en cosmetique et en dermatologie
JP2007023002A (ja) * 2005-07-21 2007-02-01 Univ Of Tsukuba 肝再生促進剤
JP4696247B2 (ja) * 2006-12-11 2011-06-08 国立大学法人 筑波大学 肝線維化抑制剤
JP5098018B2 (ja) * 2007-03-06 2012-12-12 国立大学法人 筑波大学 肝炎治療剤
EP2018835B1 (de) 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
WO2009022338A2 (en) 2007-08-16 2009-02-19 Saher Hamed Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
BRPI0821814A2 (pt) 2007-12-28 2015-06-16 Heraeus Kulzer Gmbh Uso e formulação tópica de eritropoietina para a cicatrização da pele
RU2491076C2 (ru) * 2008-03-31 2013-08-27 Аугустинус БАДЕР Способ и композиция для регенерации тканей с помощью стволовых или костномозговых клеток
CA2748147C (en) * 2008-12-24 2017-06-20 Augustinus Bader Rapid preparation and use of engineered tissue and scaffolds as individual implants
WO2011150398A1 (en) * 2010-05-28 2011-12-01 Garnet Biotherapeutics, Inc Compositions and methods of using living and non-living bioactive devices with components derived from self- renewing colony forming cells cultured and expanded in vitro
WO2012003960A1 (en) 2010-07-06 2012-01-12 Augustinus Bader Topical application of erythropoietin for the treatment of eye disorders and injuries
WO2012031778A1 (de) 2010-09-12 2012-03-15 Augustinus Bader Verwendung von erythropoietin bei der heilung von wunden oder gewebedefekten ohne narbenbildung
US20130261058A1 (en) * 2010-09-16 2013-10-03 University Of Miami Acceleration of wound healing by growth hormone releasing hormone and its agonists
JP5966129B2 (ja) * 2011-01-31 2016-08-10 オリンパス株式会社 免疫賦活剤
CN104004709B (zh) * 2014-05-05 2016-05-18 曾奕明 用于促进人胚肺成纤维细胞增殖分化的多种生长因子复合物纤维蛋白凝胶释放系统
JP7167019B2 (ja) 2016-11-10 2022-11-08 エーエスシー・リジェニティー・リミテッド エリスロポエチン由来分子を含む局所適用のための美容用製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
EP0463082A1 (en) * 1989-03-15 1992-01-02 The Regents Of The University Of California Purified ciliary neurotrophic factor
US5492891A (en) * 1991-09-05 1996-02-20 Novo Nordisk A/S Method for treatment of patients with chronic liver disease
US5427975A (en) * 1993-05-10 1995-06-27 Delco Electronics Corporation Method of micromachining an integrated sensor on the surface of a silicon wafer
CA2175203A1 (en) * 1993-11-03 1995-05-11 Thaddeus P. Pruss Hemostatic patch
US7008634B2 (en) * 1995-03-03 2006-03-07 Massachusetts Institute Of Technology Cell growth substrates with tethered cell growth effector molecules
US6419920B1 (en) * 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
JPH1067678A (ja) * 1996-06-20 1998-03-10 Chugai Pharmaceut Co Ltd 肝疾患治療用医薬組成物
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
US6274158B1 (en) * 1998-02-04 2001-08-14 Veronica L. Zaharia Czeizler Treatment with recombinant human erythropoietin of bleeding in patients with normal and abnormal hemostasis
WO2000034443A2 (en) * 1998-12-07 2000-06-15 Bartelmez Stephen H Megakaryocyte-induced expansion of hematopoietic stem cells
US6479064B1 (en) * 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6319942B1 (en) * 2001-06-06 2001-11-20 Nicholas V. Perricone Topical scar treatments using alkanolamines

Similar Documents

Publication Publication Date Title
JP2005533800A5 (https=)
CA2380072A1 (en) Nicotine in therapeutic angiogenesis and vasculogenesis
JP2022031772A5 (https=)
JP2005511635A5 (https=)
JP2007523178A5 (https=)
JP2003503454A5 (https=)
JP2005503183A5 (https=)
JP2010525073A5 (https=)
JP2007500209A5 (https=)
EP2407470A3 (en) Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
JP2005518433A5 (https=)
JP2008505857A5 (https=)
JPH11139971A5 (https=)
JP2004523498A5 (https=)
JP2006502236A5 (https=)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2006512324A5 (https=)
JP2008531742A5 (https=)
JP2008513510A5 (https=)
EP1846028A4 (en) TRANSPORT, BIOACTIVE SUBSTANCES AND VIRAL VACCINES
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
JP2007512377A5 (https=)
WO2005123055A3 (en) Methods for treating inflammatory disorders
JP2002537256A5 (https=)
WO2005011604A3 (en) Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease